Name | Value |
---|---|
Revenues | 182.0K |
Cost of Revenue | 118.0K |
Gross Profit | 64.0K |
Operating Expense | 3,327.0K |
Operating I/L | -3,270.0K |
Other Income/Expense | 1,658.0K |
Interest Income | 0.0K |
Pretax | -1,612.0K |
Income Tax Expense | 0.0K |
Net Income/Loss | -1,612.0K |
Helius Medical Technologies, Inc. is a neurotechnology company specializing in non-invasive technologies for treating symptoms of neurological disease or trauma. Its flagship product, the Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device designed for short-term treatment of gait deficit in multiple sclerosis and balance deficit in mild-to-moderate traumatic brain injury. The device is used in conjunction with supervised therapeutic exercise, offering a unique solution for patients. Helius generates revenue through the development, licensing, and acquisition of innovative medical technologies, positioning itself as a leader in the neurotechnology industry.